Application Process
Microbiology and Immunology are particularly productive in preclinical research and discovery. We are focused on pathogenic bacteria, viruses, and immunology. Our main research themes also focus on developing more effective cancer immunotherapy and an HIV vaccine, creating antigen-specific immune tolerance, and overcoming bacteria's antibiotic resistance.
Active research in immunology includes the areas of cytotoxicity, programmed cell death, cytokine receptor signaling, clinical and experimental bone marrow transplantation, stem cell biology, gene therapy for cancer treatment, antigen recognition, cell differentiation and communication, aging of the immune system, interleukins, genetic control of immunoglobulin production, gene activation and evolution of the immune response. Research in other areas includes the molecular biology of virus-host interaction in both animal and human systems, control and regulation of bacterial pathogenesis, selective tumor chemotherapy and radiation therapy, and therapy of parasitic infections.
We actively collaborate with the Sylvester Comprehensive Cancer Center and the Diabetes Research Institute. These interactions help us translate our laboratory discoveries into direct benefits for patients with cancer and type 1 diabetes. Our large portfolio of licensing agreements and start-up companies shows our efforts to translate our discoveries to the clinic.
We actively collaborate with the Sylvester Comprehensive Cancer Center and the Diabetes Research Institute. These interactions help us translate our laboratory discoveries into direct benefits for patients with cancer and type 1 diabetes. Our large portfolio of licensing agreements and start-up companies shows our efforts to translate our discoveries to the clinic.
Key Areas of Research
- Antibiotic Resistance of Bacteria
- Antigen-specific Immune Tolerance
- Cancer Immunotherapy
- Cellular & Molecular Immunology
- HIV / AIDS
- Microbial Genetics
- Pathogenic Bacteriology
- Virology